计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F651495-1mg |
1mg |
期货 ![]() |
| |
| F651495-5mg |
5mg |
期货 ![]() |
| |
| F651495-10mg |
10mg |
期货 ![]() |
|
| 英文别名 | J-009310 | CCG-204598 | 3-(8-Cyclopentyl-2,6-Dioxo-1-Propyl-7H-Purin-3-ylPropyl 4-Fluorosulfonylbenzoate | Lopac-F-7927 | SR-01000075884-1 | NCGC00093905-02 | BDBM50039676 | 8-Cyclopentyl-N3-[3-(4-(fluorosulfonyl)benzoyloxy)propyl]-N1-propylxanthine | HY- |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | FSCPX |
| 生化机理 | FSCPX 是一种强效、选择性的不可逆 A 1 腺苷受体(A 1 AR)拮抗剂,与 A 1 AR 的结合效力低至纳摩尔。FSCPX 可通过降低核苷转运抑制剂 NBTI 的间质腺苷含量来改变其作用。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 产品介绍 |
FSCPX is a potent and selective irreversible antagonist of A 1 adenosine receptor (A 1 AR) , with low nanomolar potency for binding to the A 1 AR. FSCPX could modify the effect of NBTI, a nucleoside transport inhibitor, by reducing the interstitial adenosine level in the guinea pig atrium In Vitro FSCPX irreversibly blocks the binding of [ 3 H]-8-cyclopentyl-1,3dipropylxanthine ([ 3 H]DPCPX), with an IC 50 of 11.8±3.2 nM in DDT 1 MF2 cells. FSCPX (20 μM; 48 h) attenuates protection from necrosis and apoptosis in A1AR-overexpressing LLC-PK1 cells. FSCPX (2-20 μM; 48 h) reverses the upregulation of HSP27 mRNA and protein in A1AR-overexpressing LLC-PK1 cells without an effect on the mRNA or protein for HSP70. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:A1AR |
| 纯度 | ≥99% |
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 3-(8-cyclopentyl-2,6-dioxo-1-propyl-7H-purin-3-yl)propyl 4-fluorosulfonylbenzoate |
| INCHI | 1S/C23H27FN4O6S/c1-2-12-28-21(29)18-20(26-19(25-18)15-6-3-4-7-15)27(23(28)31)13-5-14-34-22(30)16-8-10-17(11-9-16)35(24,32)33/h8-11,15H,2-7,12-14H2,1H3,(H,25,26) |
| InChi Key | XJLGXHIRSHTRPQ-UHFFFAOYSA-N |
| Smiles | CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCCOC(=O)C4=CC=C(C=C4)S(=O)(=O)F |
| Isomeric SMILES | CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCCOC(=O)C4=CC=C(C=C4)S(=O)(=O)F |
| PubChem CID | 133012 |
| 分子量 | 506.55 |
| 溶解性 | DMSO : 50 mg/mL (98.71 mM; ultrasonic and warming and heat to 60°C) |
|---|---|
| 分子量 | 506.500 g/mol |
| XLogP3 | 5.100 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 10 |
| 精确质量Exact Mass | 506.164 Da |
| 单同位素质量Monoisotopic Mass | 506.164 Da |
| 拓扑极表面积Topological Polar Surface Area | 138.000 Ų |
| 重原子数Heavy Atom Count | 35 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 898.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |